Taken together, these results suggest that CD8+ effector subgroups differ in Foxp1 expression and apoptotic response to TGF-β exposure, and that NTeff cells maintain resistance to inhibitory factors induced from the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.